Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids

Biochemical Pharmacology

Volumn 66, Issue 7, 2003, Pages 1139-1150

  Chen, Yen Chou ^a   Shen, Shing Chuan ^b,c   Lin, Hui Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Caspase 3; Hesperetin; Hesperidin; Naringenin; Naringin; Rutinoside

Indexed keywords

ANTINEOPLASTIC AGENT; AURANTIIN; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLTYROSYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; ENZYME; GLUCOSE DERIVATIVE; HESPERETIN; HESPERIDIN; HESPERIDINASE; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; NARINGENIN; NARINGINASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN; PROTEIN BAG; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; RHAMNOSE PLUS GLUCOSE; RUTINOSIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONOCYTE; MORPHOLOGICAL TRAIT; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0141852379     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00455-6     Document Type: Article

References (43)

1. Lin J.K., Chen Y.-C., Huang Y.T., Lin-Shiau S.Y. Suppression of protein kinase C and nuclear oncogene expression as possible and molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J. Cell Biochem. 28/29:1997;39-48.
2. Chen Y.-C., Shen S.-C., Lee W.R., Hou W.C., Yang L.L., Lee T.J.F. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell Biochem. 82:2001;537-548.
3. 2 in anti-promotive process. J. Cell Physiol. 193:2002;93-102.
4. Chen Y.-C., Yang L.L., Lee T.J.F. Oroxylin A inhibition of lipopolysaccahride-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochem. Pharmacol. 59:2000;1445-1457.
5. Birt D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90:2001;157-177.
6. Heijnen C.G., Haenen G.R., Oostveen R.M., Stalpers E.M., Bast A. Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic. Res. 36:2002;575-581.
7. Guthrie N., Carroll K.K. Inhibition of mammary cancer by citrus flavonoids. Adv. Exp. Med. Biol. 439:1998;227-236.
8. Ameer B., Weintraub R.A., Johnson J.V., Yost R.A., Rouseff R.L. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther. 60:1996;34-40.
9. Galati G., Chan T., Wu B., O'Brien P.J. Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids. Chem. Res. Toxicol. 12:1999;521-525.
10. Knowles L.M., Zigrossi D.A., Tauber R.A., Hightower C., Milner J.A. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr. Cancer. 38:2000;116-122.
11. Galati G., Moridani M.Y., Chan T.S., O'Brien P.J. Peroxidative metabolism of apigenin and naringenin vs. luteolin and quercetin: glutathione oxidation and conjugation. Free Radic. Biol. Med. 30:2001;370-382.
12. Guengerich F.P., Kim D.H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 11:1990;2275-2279.
13. Kawaguchi K., Kikuchi S., Hasegawa H., Maruyama H., Morita H., Kumazawa Y. Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur. J. Pharmacol. 368:1999;245-250.
14. Koyuncu H., Berkarda B., Baykut F., Soybir G., Alatli C., Gul H., Altun M. Preventive effect of hesperidin against inflammation in CD-1 mouse skin caused by tumor promoter. Anticancer Res. 19:1999;3237-3241.
15. Tanaka T., Makita H., Kawabata K., Mori H., Kakumoto M., Satoh K., Hara A., Sumida T., Fukutani K., Tanaka T., Ogawa H. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis. 18:1997;761-769.
16. Galati E.M., Trovato A., Kirjavainen S., Forestieri A.M., Rossitto A., Monforte M.T. Biological effects of hesperidin, a citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat. Farmacology. 51:1996;219-221.
17. Buening M.K., Chang R.L., Huang M.T., Fortner J.G., Wood A.W., Conney A.H. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41:1981;67-72.
18. Melzig M.F., Loose R. Inhibition of lipopolysaccharide (LPS)-induced endothelial cytotoxicity by selected flavonoids. Planta Med. 64(5):1998;397-399.
19. Chen Y.-C., Shen S.-C., Lee W.R., Hsu F.L., Lin H.-Y., Ko C.H., Tseng S.W. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase-3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 64:2002;1713-1724.
20. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., Kong T.A.N. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58:2000;402-408.
21. Green D.R. Apoptotic pathways: the roads to ruin. Cell. 94(6):1998;695-698.
22. Chen Y.-C., Shen S.-C., Lee W.R., Lin H.-Y., Ko C.H., Shih C.M. Wogonin and fisetin induction of apoptosis through activation of caspase-3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch. Toxicol. 76:2002;351-359.
23. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:2000;1-4.
24. Soldani C., Lazze M.C., Bottone M.G., Tognon G., Biggiogera M., Pellicciari C.E., Scovassi A.I. Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where? Exp. Cell Res. 269:2001;193-201.
25. Krieser R.J., Eastman A. Cleavage and nuclear translocation of the caspase-3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis. Cell Death Diff. 6:1999;412-419.
26. 2 production. Eur. J. Pharmacol. 446:2002;187-194.
27. Chen Y.-C., Shen S.-C., Chen L.G., Lee T.J.F., Yang L.L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expression induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61:2001;1417-1427.
28. Cioca D.P., Kitano K. Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells. Cell Mol. Life Sci. 59:2002;1377-1387.
29. Lenoir M., Pedruzzi E., Rais S., Drieu K., Perianin A. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginko Biloba extract EGB761. Biochem. Pharmacol. 63:2002;1241-1249.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
31. Romero C., Manjon A., Bastida J., Iborra J.L. A method for assaying the rhamnosidase activity of naringinase. Anal. Biochem. 149:1985;566-571.
32. Ficarra R., Tommasini S., Raneri D., Calabro M.L., Di Bella M.R., Rustichelli C., Gamberini M.C., Ficarra P. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation. J. Pharmaceutic. Biomed. Anal. 29:2002;1005-1014.
33. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22:2002;19-34.
34. Piskula M.K. Factors affecting flavonoids absorption. Biofactors. 12:2000;175-180.
35. Kim D.H., Jung E.A., Sohng I.S., Han J.A., Kim T.H., Han M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharma. Res. 21:1998;17-23.
36. Ioku K., Aoyama Y., Tokuno A., Terao J., Nakatani N., Takei Y. Various cooking methods and the flavonoid content in onion. J. Nutr. Sci. Vitaminol. 47:2001;78-83.
37. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci. Biotechnol. Biochem. 64:2000;1813-1820.
38. Blankson H., Grotterod E.M., Seglen P.O. Prevention of toxin-induced cytoskeletal disruption and apoptotic liver cell death by the grapefruit flavonoid, naringin. Cell Death Differ. 7:2000;739-746.
39. Honkakoski P., Negishi M. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem. J. 330:1998;889-895.
40. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22:1997;749-760.
41. 2+-dependent endonuclease. Biochem. Pharmacol. 63:2002;225-236.
42. Chen Y.-C., Lin-Shiau S.Y., Lin J.K. Involvement of p53 and HSP70 proteins in attenuation of UVC-induced apoptosis by thermal stress in hepatocellular carcinoma cells. Photochem. Photobiol. 70:1999;78-86.
43. Chen Y.-C., Lin-Shiau S.Y., Lin J.K. Involvement of reactive oxygen species and caspase-3 activation in arsenite-induced apoptosis. J. Cell Physiol. 177:1998;324-333.